Jan 31 (Reuters) - Instil Bio Inc TIL.O :
* INSTIL BIO ANNOUNCES EXTENSION OF CASH RUNWAY BEYOND 2026
WITH
THE CONSOLIDATION OF RESEARCH AND DEVELOPMENT OPERATIONS TO ITS
MANCHESTER, U.K. SITE
* INSTIL TO EXTEND PREVIOUSLY ANNOUNCED REDUCTION-IN-FORCE
TO
REDUCE US HEADCOUNT
* INITIAL CLINICAL DATA FROM ITIL-306 PROGRAM EXPECTED IN
2023
* EVALUATING POTENTIAL SALE/SUBLEASE OF TARZANA
MANUFACTURING
SITE, OTHER FACILITIES CURRENTLY UNDER LEASE, TO EXTEND CASH
RUNWAY
Source text for Eikon: ID:nGNXSTygv
Further company coverage: TIL.O